# Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results Canonical URL: https://biopharmsignal.com/news/TECH/bio-techne-to-host-conference-call-on-may-6-2026-to-announce-third-quarter-fiscal-2026-financial-results Ticker: TECH Company: Bio-Techne Source: Bio-Techne Published: 2026-04-14 11:00 EST Original Source URL: https://investors.bio-techne.com ## Summary

MINNEAPOLIS, April 14, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m. CDT to review its third ## Article Body MINNEAPOLIS, April 14, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m. CDT to review its third quarter fiscal 2026 financial results. Access to the discussion may be obtained as follows: Time: 8:00 a.m. CDT Date: May 6, 2026 Dial-in: 1-800-343-4136 or 1-203-518-9843 (for international callers) Conference ID: TECHQ3 Webcast: https://investors.bio-techne.com/ir-calendar A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11161556. The replay will be available from 11:00 a.m. CDT on Wednesday, May 6, 2026, until 11:00 p.m. CDT on Saturday, June 6, 2026. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at LinkedIn, X, or YouTube. Contact: David Clair, Vice President, Investor Relations david.clair@bio-techne.com 612-656-4416 View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-may-6-2026-to-announce-third-quarter-fiscal-2026-financial-results-302741254.html SOURCE Bio-Techne Corporation ## Recent Company News - 2026-07-08 10:30 EST — [Bio-Techne Launches Expanded R&D Systems AI-Engineered Designer Protein Portfolio](https://biopharmsignal.com/news/TECH/bio-techne-launches-expanded-r-d-systems-ai-engineered-designer-protein-portfoli-21b908e1) — Source: Bio-Techne - 2026-06-25 10:10 EST — [Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets](https://biopharmsignal.com/news/TECH/merck-kgaa-darmstadt-germany-agrees-to-acquire-bio-techne-strengthening-leadersh-50e2ac1c) — Source: Bio-Techne - 2026-06-04 10:30 EST — [Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization](https://biopharmsignal.com/news/TECH/bio-techne-and-refeyn-close-critical-gap-in-bispecific-antibody-and-biosimilar-characterization) — Source: Bio-Techne - 2026-05-06 10:30 EST — [Bio-Techne Declares Dividend](https://biopharmsignal.com/news/TECH/bio-techne-declares-dividend) — Source: Bio-Techne - 2026-05-06 10:30 EST — [Bio-Techne Releases Third Quarter Fiscal 2026 Results](https://biopharmsignal.com/news/TECH/bio-techne-releases-third-quarter-fiscal-2026-results) — Source: Bio-Techne ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)